banner banner banner banner banner banner

Upcoming events

3rd Congress of the European Academy of Neurology
Sat 24 June - Tue 27 June 2017
Read more
21st International Congress of Parkinson’s Disease & Movement Disorders
Sun 4 June - Thu 8 June 2017
Read more

Britannia at a glance

Britannia Pharmaceuticals, part of the STADA Arzneimittel AG group of companies, is a UK based pharmaceutical company.  We specialise in innovative products for chronic and serious medical conditions, and in particular, the treatment of Parkinson’s disease. We are highly committed to improving the quality of life for People with Parkinson's disease.

Our key product Apomorphine Hydrochloride (Brand names: APO-go, APOKYN, MOVAPO) is a treatment for Parkinson’s disease which is available in many markets through our Distribution or Licensing Partners.